These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5457828)

  • 1. Myasthenia gravis. Binding of antibodies to muscle tissue.
    Aarli JA
    Acta Neurol Scand; 1970; 46(S43):211-212. PubMed ID: 5457828
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiglobulin consumption test with sera from patients with myasthenia gravis.
    Aarli JA; Tönder O
    Clin Exp Immunol; 1970 Jul; 7(1):11-21. PubMed ID: 4098288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymus and myasthenia gravis. Review of 200 cases, with experimental studies on anti-muscle antibodies and lymphocyte function.
    Kano S; Takaku F; Uono M
    Nihon Ketsueki Gakkai Zasshi; 1971 Aug; 34(4):420-7. PubMed ID: 5170455
    [No Abstract]   [Full Text] [Related]  

  • 5. Delayed hypersensitivity to muscle and thymus in myasthenia gravis and polymyositis.
    Goust JM; Castaigne A; Moulias R
    Clin Exp Immunol; 1974 Sep; 18(1):39-47. PubMed ID: 4478858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myasthenia gravis. Immunologic aspects].
    Aarli JA
    Tidsskr Nor Laegeforen; 1971 Apr; 91(11):819-21. PubMed ID: 4103765
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis, autoimmunity and the thymus.
    Strauss AJ
    Adv Intern Med; 1968; 14():241-80. PubMed ID: 4178674
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.
    Behan WM; Behan PO; Simpson JA
    J Neurol Neurosurg Psychiatry; 1975 Nov; 38(11):1039-47. PubMed ID: 1206412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis.
    Mittag T; Kornfeld P; Tormay A; Woo C
    N Engl J Med; 1976 Mar; 294(13):691-4. PubMed ID: 1250280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies.
    Gilhus NE; Aarli JA; Matre R
    Acta Neurol Scand; 1983 Nov; 68(5):328-36. PubMed ID: 6364682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of specific antineuronal nuclear antibodies in sera of patients with myasthenia gravis. Indirect and direct immunofluorescence.
    Martin L; Herr JC; Wanamaker W; Kornguth S
    Neurology; 1974 Jul; 24(7):680-3. PubMed ID: 4600589
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophoretic immunoblotting analysis of anti-thymus microsome antibodies in patients with myasthenia gravis.
    Hazama T; Takahashi M; Ueno S; Tarui S
    Acta Neurol Scand; 1989 Feb; 79(2):88-96. PubMed ID: 2711826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myasthenia gravis. Antibodies to an acid-soluble antigen in striated muscle.
    Aarli JA
    Clin Exp Immunol; 1972 Mar; 10(3):453-61. PubMed ID: 4624498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myasthenia gravis: an autoimmune theory].
    Uono M
    Nihon Rinsho; 1973 Dec; 31(12):3387-93. PubMed ID: 4598899
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological aspects of myasthenia gravis.
    Lessof MH
    Proc R Soc Med; 1968 Aug; 61(8):759-60. PubMed ID: 5673395
    [No Abstract]   [Full Text] [Related]  

  • 16. Myasthenia gravis and immunity. A review of basic mechanisms.
    Ryan M; Egbert B; Ziegler DK
    J Kans Med Soc; 1973 Mar; 74(3):72-7. PubMed ID: 4120480
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: Myasthenia gravis: autoimmunity, etiology and pathogenesis.
    Strauss AJ
    N Engl J Med; 1975 Mar; 292(11):594. PubMed ID: 1110682
    [No Abstract]   [Full Text] [Related]  

  • 18. IgG subclass distribution of myasthenia gravis thymoma-associated antiskeletal muscle antibodies.
    Smith CI; Aarli JA; Hammarström L; Persson MA
    Neurology; 1984 Aug; 34(8):1094-6. PubMed ID: 6540388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective impairment of serum antibody repertoires toward muscle and thymus antigens in patients with seronegative and seropositive myasthenia gravis.
    Sharshar T; Lacroix-Desmazes S; Mouthon L; Kaveri S; Gajdos P; Kazatchkine MD
    Eur J Immunol; 1998 Aug; 28(8):2344-54. PubMed ID: 9710212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocyte migration response to purified muscle antigen in myasthenia gravis patients.
    Chiu HC; Chen RC; Hung TP; Deng JS
    Taiwan Yi Xue Hui Za Zhi; 1980 Nov; 79(11):977-85. PubMed ID: 6942100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.